Skip to content

Alzheimer's Research & Therapy

Article image

Featured research article: Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

"Minimally invasive specific biomarkers of neurodegenerative diseases (NDs) would facilitate patient selection and disease progression monitoring. We describe the assessment of circulating brain-enriched microRNAs as potential biomarkers for Alzheimer’s disease (AD)"


  1. Content type: Research


    Authors: Ross W. Paterson, Catherine F. Slattery, Teresa Poole, Jennifer M. Nicholas, Nadia K. Magdalinou, Jamie Toombs, Miles D. Chapman, Michael P. Lunn, Amanda J. Heslegrave, Martha S Foiani, Philip S. J. Weston, Ashvini Keshavan, Jonathan D. Rohrer, Martin N. Rossor, Jason D. Warren, Catherine J. Mummery…

View all articles
View all articles

Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

New Content Item

Featured commentary: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease

"This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh... Since treatments are likely to be most effective in the early stages, identification of clinically relevant brain changes will be crucial."

Alzheimer's Disease International news

ADI 2018 is the longest running and most diverse international conference on dementia. The conference will feature leading experts on a range of topics including the latest in dementia science and care, presentations by people with dementia and their care partners, discussions on prevention, diagnosis, engaging minority groups and a unique focus on how technology and innovation is shaping the future.

Submit your abstract here by 31 January

Latest Tweets


Affiliated with

2016 Journal Metrics